SYNTA PHARMACEUTICALS
Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. It has a global partnership with Roche for developing novel CRACM inhibitors, an oral calcium released activated calcium modulator ion channel inhibitor program that is in the lead optimization stage for the treatment of autoimmune disea... ses. The company also retains rights in various indications and markets to its other drug candidates and programs, which include STA-9090, an Hsp90 inhibitor that is in Phase 1 development; elesclomol, an oxidative stress inducer for the treatment of cancer; and apilimod, an oral IL-12/23 inhibitor, which is in Phase 2 for rheumatoid arthritis. In addition, Synta Pharmaceuticals Corp. is developing STA-9584, a vascular disrupting agent that is in preclinical development. The company was incorporated in 2000 and is based in Lexington, Massachusetts.
SYNTA PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2000-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.syntapharma.com
Total Employee:
51+
Status:
Active
Contact:
(781) 274-8200
Email Addresses:
[email protected]
Total Funding:
217.35 M USD
Technology used in webpage:
SPF Amazon Google Maps GoDaddy DNS Google Maps API AWS Global Accelerator AppRiver
Similar Organizations
3Z Pharmaceuticals
3Z Pharmaceuticals focuses on developing drugs that would improve the central nervous system.
AltruBio
AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.
Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Alion Pharmaceuticals
Alion Pharmaceuticals is on developing a pipeline of small molecules with high potential
Anthera Pharmaceuticals
Anthera Pharmaceuticals is focused on developing products to treat diseases associated with inflammation and autoimmune diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arena Pharmaceuticals
Arena Pharmaceuticals is focused on delivering solutions for cardiovascular, central nervous system, inflammatory and metabolic diseases.
Berry Genomics
Berry Genomics is a company specializing in developing and commercializing technologies for life sciences and clinical applications.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Boston Therapeutics
Boston Therapeutics develops and commercializes novel compounds for unmet medical needs in the areas of diabetes and inflammatory diseases.
Astria Therapeutics
Astria Therapeutics discovers and develops innovative drugs for treating inflammatory conditions.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Concert Pharmaceuticals
Concert Pharmaceuticals is a biotechnology company utilizing deuterium to develop novel medical candidates.
Dynamis Pharmaceuticals
Dynamis Pharmaceuticals is a biopharma company that is developing proprietary small molecule drugs to treat chronic inflammatory diseases.
Enanta Pharmaceuticals
Enanta Pharmaceuticals is an R&D company discovers, develops and promotes of small molecule drugs in the areas of anti-infective.
Eolo Pharma
Eolo Pharma focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases
Kiora Pharmaceuticals
Kiora Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.
Glycovax Pharma
Glycovax Pharma focuses on developing nano-medicines to treat cancers and other diseases.
Haemalogix
Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.
HebeCell
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.
Icon Bioscience
Icon Bioscience develops and commercializes novel ophthalmic pharmaceuticals through a proprietary drug delivery platform.
KalGene Pharmaceuticals
KalGene Pharmaceuticals is a biotech company that develops precision medicine therapeutics for patients suffering from Alzheimer's disease.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Nirogy Therapeutics
Nirogy Therapeutics is focusing on small-molecule drugs that target the solute carrier family of transporter proteins (SLCTs).
OncoArendi Therapeutics
OncoArendi Therapeutics specialized in developing and commercializing of therapeutics for neoplastic and inflammatory diseases.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.
Renew Biopharma Inc.
Pre-clinical stage syn-bio creating proprietary drug molecules to treat neuroinflammatory diseases .
Ritter Pharmaceuticals
Ritter Pharmaceuticals discovers and commercializes treatments for gastrointestinal diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals is a discovery company developing a new class of pharmaceuticals called small molecule nucleic acid hybrids.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Venatorx Pharmaceuticals
Venatorx Pharmaceuticals develops a novel anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-04-14 | Madrigal Pharmaceuticals | Madrigal Pharmaceuticals acquired by Synta Pharmaceuticals | 253.9 M USD |
Investors List
Galleon Group
Galleon Group investment in Series C - Synta Pharmaceuticals
Duquesne Capital Management
Duquesne Capital Management investment in Series C - Synta Pharmaceuticals
Mountain Trail Investments
Mountain Trail Investments investment in Series C - Synta Pharmaceuticals
SunAmerica
SunAmerica investment in Series C - Synta Pharmaceuticals
Caxton Associates
Caxton Associates investment in Series C - Synta Pharmaceuticals
Gollust Management
Gollust Management investment in Series C - Synta Pharmaceuticals
Official Site Inspections
http://www.syntapharma.com
- Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
- IP address: 3.33.152.147
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
